Why Prevention-Focused Strategies Are Key
Five ways stakeholders can promote screening and treatment for elevated Lp(a) in the future to improve overall cardiac disease mortality
Cynthia Miller</a> brings over 15 years of experience in the healthcare field. She is trained as an internist with a Master’s in Public Health. She has extensive experience in patient care delivery in the outpatient setting, and experience in inpatient care, palliative care, and telemedicine. Before joining <a href=https://medcitynews.com/author/cmiller/"https://www.precisionvalue.com/">Precision AQ</a>, Cynthia served as the Senior Medical Director of Pharmacy for WellCare Health Plans and later as Vice President Medical Director in Pharmacy at Centene. Currently, she is Vice President Medical Director in the Access Experience Team at Precision AQ, where she assists clients in developing and implementing payer strategies for pharmaceutical products across the lifecycle." />
Five ways stakeholders can promote screening and treatment for elevated Lp(a) in the future to improve overall cardiac disease mortality